SHC: Barclays Raises PT
Barclays maintains overweight rating on Sotera Health and raises price target to $19
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19
Barclays maintains overweight rating on Sotera Health and raises price target to $19
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19